Abstract
Novel retinoic acid metabolism blocking agent (RAMBA), VN/12-1, is a highly potent anti-cancer agent that induces autophagy. Its combination with autophagy inhibitor chloroquine (CHL) has been shown to synergistically enhance apoptosis in breast cancer cells. The purpose of this study was to determine the toxicity and pharmacokinetic profile of VN/12-1 and its combination with CHL. Preliminary toxicology of VN/12-1 was determined using female SCID mice (n = 4 for each group). ATRA was used for comparison. We selected four different doses of VN/12-1 and ATRA. Two of the doses were low and less frequent (2.5 and 5 mg/kg twice a week), and the remaining doses were high and more frequent (10 and 20 mg/kg every day). The dose of CHL was 50 mg/kg twice a week. For pharmacokinetic (PK) study, 20 mg/kg of VN/12-1 was injected subcutaneously (s.c.) into the mice, and their plasma was collected at various intervals (n = 2) and analyzed by HPLC. The lower and less frequent doses of VN/12-1 and ATRA were found to be least toxic. However, high and more frequent doses of these compounds were toxic to the mice. PK results showed that VN/12-1 has a half-life of 6 h. The area under the curve (AUC) for VN/12-1 was 83.78 h μg/ml. VN/12-1 and ATRA...Continue Reading
References
Dec 23, 1994·Journal of Medicinal Chemistry·M F VaeziD D Muccio
Mar 1, 1997·Drugs·C E OrfanosC C Geilen
Oct 9, 2002·Mini Reviews in Medicinal Chemistry·V C O Njar
Dec 24, 2004·Journal of Medicinal Chemistry·Jyoti B PatelVincent C O Njar
Jul 22, 2005·Journal of Medicinal Chemistry·Lalji K GediyaVincent C O Njar
Feb 2, 2006·British Journal of Cancer·C K HuynhV C O Njar
Mar 15, 2006·Bioorganic & Medicinal Chemistry·Vincent C O NjarJyoti Patel
Aug 9, 2006·European Journal of Clinical Investigation·C J ChangW Y Lui
Dec 6, 2006·Cancer Research·Aashvini BelosayVincent C O Njar
Mar 9, 2007·Cancer Chemotherapy and Pharmacology·Jyoti B PatelVincent C O Njar
Mar 28, 2007·British Journal of Cancer·J B PatelV C O Njar
Apr 21, 2007·Nature Reviews. Cancer·Karen T LibyMichael B Sporn
Oct 2, 2007·Nature Reviews. Drug Discovery·Lucia AltucciHinrich Gronemeyer
Jan 2, 2008·Bioorganic & Medicinal Chemistry·Lalji K GediyaVincent C O Njar
Mar 20, 2008·British Journal of Cancer·A KhandelwalVco Njar
Jun 12, 2008·Journal of Medicinal Chemistry·Lalji K GediyaVincent C O Njar
Nov 19, 2009·Cancer Research·Lei FuShi-Yong Sun
Aug 16, 2011·Breast Cancer Research and Treatment·Paul E GossVincent C O Njar
Feb 16, 2012·Molecular Cancer Therapeutics·Abhijit M GodboleVincent C O Njar